The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Increased Serum Concentration of Angiogenic Factors in Malignant Melanoma Patients Correlates With Tumor Progression and Survival
Abstract
PURPOSE: To determine the predictive value of the angiogenic serum factors angiogenin, vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and interleukin-8 (IL-8) for the prognosis of patients with malignant melanoma. PATIENTS AND METHODS: Angiogenin, VEGF, bFGF, and IL-8 were measured in sera of 125 melanoma patients with different stages of disease and with or without current therapy including interferon alfa and different cytostatics in comparison with 30 healthy controls using enzyme-linked immunosorbent assay. RESULTS: Serum levels of angiogenin, VEGF, bFGF, and IL-8 were significantly increased in melanoma patients compared with healthy controls. Elevated serum concentrations of VEGF, bFGF, and IL-8 were associated with advanced disease stages and tumor burden. Cytostatic therapy of patients was accompanied by increased serum levels of angiogenin, bFGF, and IL-8. As shown by univariate analysis, elevated serum levels of VEGF (P = .0001 and .0036), bFGF (P < .00005 and < .00005), and IL-8 (P < .00005 and < .00005) were strongly correlated with a poor overall and progression-free survival, respectively. Multivariate analysis revealed stage of disease (P = .0238), tumor burden (P = .0347), VEGF (P = .0036), bFGF (P = .0252), and IL-8 (P = .0447) as independent predictive factors of overall survival. Tumor burden (P = .0081), VEGF (P = .0245), and IL-8 (P = .0089) were found as independent predictive factors of progression-free survival. CONCLUSION: Our data suggest that the angiogenic serum factors VEGF, bFGF, and IL-8 are useful predictive markers for overall and progression-free survival in melanoma patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma
Weidner, N., Semple, J. P., Welch, W. R., & Folkman, J. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101033240101 · Cited by 5,627
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Molecular and biological properties of vascular endothelial growth factor
Ferrara, N. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900019 · Cited by 1,158
Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L. D., Carbone, D. P., & Gabrilovich, D. I. (1998) · PubMed · Cited by 530
Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., & Gabrilovich, D. I. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.3.1224 · Cited by 481
IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
Schadendorf, D., Möller, A., Algermissen, B., Worm, M., Sticherling, M., & Czarnetzki, B. M. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.5.2667 · Cited by 412
Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., NAKAYAMA, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · PubMed · Cited by 363
Yamamoto, S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., & Mori, T. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.537 · Cited by 356
Wang, Y., & Becker, D. (1997) · Nature Medicine · doi:10.1038/nm0897-887 · Cited by 284
Torisu, H., Ono, M., Kiryu, H., Furue, M., Ohmoto, Y., Nakayama, J., Nishioka, Y., Sone, S., & Kuwano, M. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000115)85:2%3c182::aid-ijc6%3e3.0.co;2-m · Cited by 254
Salven, P., Teerenhovi, L., & Joensuu, H. (1997) · Blood · doi:10.1182/blood.v90.8.3167 · Cited by 249
Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma
Bar-Eli, M. (1999) · Pathobiology · doi:10.1159/000028045 · Cited by 247
Yamamoto, Y., Toi, M., Kondo, S., Matsumoto, T., Suzuki, H., Kitamura, M., Tsuruta, K., Taniguchi, T., Okamoto, A., Mori, T., et al. (1996) · PubMed · Cited by 244
Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer
Hyodo, I., Doi, T., Endo, H., Hosokawa, Y., Nishikawa, Y., Tanimizu, M., Jinno, K., & Kotani, Y. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00282-2 · Cited by 175
Shih, C.-H., Ozawa, S., Ando, N., Ueda, M., & Kitajima, M. (2000) · PubMed · Cited by 164
Hypoxia-induced up-regulation of angiogenin in human malignant melanoma.
Hartmann, A., Kunz, M., Köstlin, S., Gillitzer, R., Toksoy, A., Bröcker, E. B., & Klein, C. E. (1999) · PubMed · Cited by 160
Russo, C. L., Pellarin, M., Tingby, O., Bollen, A. W., Lamborn, K. R., Mohapatra, G., Collins, V. P., & Feuerstein, B. G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990715)86:2<316::aid-cncr16>3.0.co;2-t · Cited by 153
Enhanced expression of vascular endothelial growth factor in metastatic melanoma
Salvén, P., Heikkilä, P., & Joensuu, H. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.486 · Cited by 151
Significance of vessel count and vascular endothelial growth factor in human esophageal carcinomas.
Kitadai, Y., Haruma, K., Tokutomi, T., Tanaka, S., Sumii, K., Carvalho, M. J., Kuwabara, M., Yoshida, K., Hirai, T., Kajiyama, G., et al. (1998) · PubMed · Cited by 140
Dosquet, C., Coudert, M., Lepage, É., Cabané, J., & Richard, F. (1997) · PubMed · Cited by 139
Scheibenbogen, C., hler, T. M., Häfele, J., HUNSTEIN, W., & Keilholz, U. (1995) · Melanoma Research · doi:10.1097/00008390-199506000-00006 · Cited by 125
Reed, J. A., McNutt, N. S., & Albino, A. P. (1994) · PubMed · Cited by 100
PROGNOSTIC SIGNIFICANCE OF MICROVESSEL COUNT IN LOW STAGE RENAL CELL CARCINOMA
Yoshino, S., Kato, M., & Okada, K. (1995) · International Journal of Urology · doi:10.1111/j.1442-2042.1995.tb00445.x · Cited by 96
Li, D., Bell, J., Brown, A., & Berry, C. L. (1994) · The Journal of Pathology · doi:10.1002/path.1711720203 · Cited by 94
Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.
Shimoyama, S., Yamasaki, K., Kawahara, M., & Kaminishi, M. (1999) · PubMed · Cited by 79
Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin
Singh, R. K., Varney, M. L., Bucana, C. D., & Johansson, S. L. (1999) · Melanoma Research · doi:10.1097/00008390-199908000-00007 · Cited by 78
Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumors
van Hinsbergh, V. W. M., Collen, A., & Koolwijk, P. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_4.s60 · Cited by 43
International Trends in Cutaneous Melanoma
Swerdlow, A. J. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb32071.x · Cited by 34
Cited by
Tumor Self-Seeding by Circulating Cancer Cells
Kim, M.-Y., Oskarsson, T., Acharyya, S., Nguyen, D. X., Zhang, X. H.-F., Norton, L., & Massagué, J. (2009) · Cell · doi:10.1016/j.cell.2009.11.025 · Cited by 1,335
The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis
McAllister, S. S., & Weinberg, R. A. (2014) · Nature Cell Biology · doi:10.1038/ncb3015 · Cited by 966
Kusumanto, Y. H., Dam, W. A., Hospers, G. A. P., Meijer, C., & Mulder, N. H. (2003) · Angiogenesis · doi:10.1023/b:agen.0000029415.62384.ba · Cited by 530
A Comparative Review of Melanocytic Neoplasms
Smith, S. H., Goldschmidt, M. H., & McManus, P. M. (2002) · Veterinary Pathology · doi:10.1354/vp.39-6-651 · Cited by 431
Ning, Y., Manegold, P. C., Hong, Y. K., Zhang, W., Pohl, A., Lurje, G., Winder, T., Yang, D., LaBonte, M. J., Wilson, P. M., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.25562 · Cited by 406
Metadata
- Authors
- Ugurel, S., Rappl, G., Tilgen, W., & Reinhold, U.
- Venue
- Journal of Clinical Oncology
- Published
- 2001-01-15
- Volume
- 19
- Issue
- 2
- Pages
- 577-583
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1916387106
- Cited by
- 399
- References
- 31
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.